Alnylam Pharmaceuticals, Inc. (ALNY) — Dilution Risk Analysis
Current Snapshot
Alnylam Pharmaceuticals, Inc. (ALNY) has a DilutionWatch score of 10/10 and is classified as LOW risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 10/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
Recent filing forms in the source payload: FORM 4 1, 3 1, 4 8.
| Form | Filed | Accession |
|---|---|---|
| Form 4 | 2026-09-19 | 0001178670-26-000065|0001446125|2026-09-19|A|107 |
| 3 | 2026-04-07 | 0001178670-26-000012 |
| 4 | 2026-03-06 | 0001735276-26-000063 |
| 4 | 2026-03-04 | 0001735276-26-000048 |
| 4 | 2026-03-04 | 0001735276-26-000050 |
| 4 | 2026-03-04 | 0001735276-26-000052 |
| 4 | 2026-03-02 | 0001735276-26-000039 |
| 4 | 2026-03-02 | 0001735276-26-000040 |
| 4 | 2026-03-02 | 0001735276-26-000041 |
| 4 | 2026-02-25 | 0001735276-26-000032 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Cash runway | 38 months | Source |
| Three-year share count growth | 6.63% | Source |
DilutionWatch Analysis
- Risk Level
- LOW (Score: 10/10) Source
- Cash Runway
- 38 months Source
- Share Count Growth (3-Year)
- 6.63% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.